Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CME GroupCME -0.11%84 Earnings per Share (Diluted) is $11.79 as of Jun. 2026. GuruFocus rates CME with a GF Score™ of 84/100 and a GF Value™ of $271.35 (Fairly Valued). The stock has 3 warning signs investors should review. Among 583 Capital Markets companies, CME Group ranks worse than 53.69% on this metric.
CME Group's EPS (Basic) for the
three
months ended in Jun. 2026 was $2.89.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $11.88.
CME Group's EPS without NRI for the
three
months ended in Jun. 2026 was $2.99.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $11.80.
During the past 12 months, CME Group's average EPS without NRIGrowth Rate was 7.70% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 12.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 12.10% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 10.40% per year.
During the past 13 years, CME Group's highest 3-Year average EPS without NRI Growth Rate was 45.70% per year. The lowest was -14.90% per year. And the median was 13.50% per year.
CME Group (NAS:CME) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
CME Group Earnings per Share (Diluted) Related Terms
CME Group Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for CME Group's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME vs ICE, MCO, SPGI: Earnings per Share (Diluted) Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group PE Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's PE Ratio distribution charts can be found below:
* The bar in red indicates where CME Group's PE Ratio falls into.
CME Group Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
CME Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $11.79 mean?
CME Group (CME) has a Earnings per Share (Diluted) of $11.79 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on CME Group and its competitors. According to the industry distribution chart, CME Group ranks #313 out of 583 companies in the Capital Markets industry, placing it in the top 53.7%.
Is CME Group's Earnings per Share (Diluted) too high?
CME Group's current Earnings per Share (Diluted) is $11.79. The Capital Markets industry median Earnings per Share (Diluted) is 15.30. CME Group's value of $11.79 is 22.9% below this industry median. Based on the distribution chart, CME Group ranks #313 out of 583 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Earnings per Share (Diluted) compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #313 out of 583 companies for Earnings per Share (Diluted). This places CME Group in the lower half of its industry. The industry median Earnings per Share (Diluted) is 15.30. CME Group's value of $11.79 is 22.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Capital Markets company?
The median Earnings per Share (Diluted) among Capital Markets companies is 15.30, based on 583 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Earnings per Share (Diluted) of $11.79 is 22.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Earnings per Share (Diluted) is 15.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Earnings per Share (Diluted) is $11.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Fairly Valued. The stock's GF Value™ is $271.35, compared to a current price of $264.03 — trading 2.7% below its estimated fair value. The current Earnings per Share (Diluted) is $11.79 and 22.9% below the Capital Markets industry median of 15.30. CME Group's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For CME Group (CME), the current Earnings per Share (Diluted) is $11.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $264.03 is trading 2.7% below its estimated GF Value™ of $271.35.
GuruFocus considers CME Group to be Fairly Valued.
Key valuation signals for CME:
Earnings per Share (Diluted): $11.79
GF Value™: $271.35 vs. price of $264.03 (2.7% below fair value)
Industry Position: 22.9% below the Capital Markets median (#313 of 583)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
84GF Score
Get the complete analysis for CME
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
